Real-time · AI · Cross-signal
Virica Biotech Inc. just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on Virica Biotech Inc., plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Virica Biotech and Ginkgo Bioworks Partner to Enhance AAV Gene Therapy Manufacturing
Oct 03, 2024•over 1 year ago
Contract Type
partnership
OttawaBiotechnologyDescription
Virica Biotech Inc. and Ginkgo Bioworks, Inc. announced a strategic partnership to enhance each company’s adeno-associated virus (AAV) gene therapy manufacturing platforms. This collaboration aims to tackle the high cost of AAV-based gene therapies manufacturing, leveraging the advanced capabilities of both companies to reduce production costs and make gene therapies more accessible to patients.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months